Hungarian SME is looking for Turkish manufacturing company of small molecules and university research group for joint Turkish-Hungarian bilateral grant application.
A Hungarian pharma/biotechnology R&D company is developing novel matrix metalloproteinase inhibitor small molecules for treatment of ischemic diseases, e.g. ischemic cardiac disease, such as e.g. acute myocardial infarction. The company seeks partners to further develop the molecules in a joint Hungarian-Turkish grant application. Turkish partners needed: small molecule manufacturing company and university research group with experience in lead optimization with in silico platform.